Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2018 Filed Oct 2, 2018 19:43 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantPhantom Stock Units · Derivative | 181.783 | $0.00 Strike: $130.65 | $0.00 |
DisclosureSEC source: 0000911916-18-000175 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,953.51 Underlying: Common Stock · 181.783 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F4 · balance_after: Includes 16.292 phantom stock units accrued on July 31, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 21, 2018 Filed Sep 25, 2018 20:33 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,100 | $0.00 Strike: $39.94 | $0.00 |
DisclosureSEC source: 0000911916-18-000173 · edgar.xml · derivative · entry 3 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,100 shares Expires 2019-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Vested annually over four years in increments of 25% each year, commencing on February 17, 2010. Read SEC document |
| September 21, 2018 Filed Sep 25, 2018 20:33 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
SaleCommon Stock | 30,100 | $132.37 | $3,984,276.80 |
DisclosureSEC source: 0000911916-18-000173 · edgar.xml · nonDerivative · entry 2 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,258 F1 · shares: Securities acquired or sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Mr. Phipps on August 30, 2018. Read SEC document |
| September 21, 2018 Filed Sep 25, 2018 20:33 UTC |
Phipps Chad FSr. VP/Gen Counsel/Secretary
|
Exercise / conversionCommon Stock | 30,100 | $39.94 | $1,202,194.00 |
DisclosureSEC source: 0000911916-18-000173 · edgar.xml · nonDerivative · entry 1 Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Securities acquired or sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Mr. Phipps on August 30, 2018. F2 · balance_after: Includes 80 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between February 1, 2018 and June 29, 2018 and 161 shares purchased between February 1, 2018 and July 31, 2018 under the dividend reinvestment plan for the Company's common stock. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 20:19 UTC |
Deltort DidierPresident, EMEA
|
GrantRestricted Stock Units · Derivative | 6,216 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000166 · edgar.xml · derivative · entry 2 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,216 Underlying: Common Stock · 6,216 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on September 4, 2019. F1 · derivative.expiration_date: Vests annually over four years in increments of 25% each year, commencing on September 4, 2019. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 20:19 UTC |
Deltort DidierPresident, EMEA
|
GrantEmployee Stock Option (right to buy) · Derivative | 15,912 | $0.00 Strike: $123.02 | $0.00 |
DisclosureSEC source: 0000911916-18-000166 · edgar.xml · derivative · entry 1 Deltort Didier · CIK 0001749419 · President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,912 Underlying: Common Stock · 15,912 shares Expires 2028-09-04 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on September 4, 2019. Read SEC document |
| August 31, 2018 Filed Sep 4, 2018 10:03 UTC |
Hanson Bryan CDirector · President and CEO
|
PurchaseCommon Stock | 410 | $123.03 | $50,442.30 |
DisclosureSEC source: 0000911916-18-000162 · edgar.xml · nonDerivative · entry 1 Hanson Bryan C · CIK 0001524349 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,487 Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 16:07 UTC |
Florin Daniel PExec. VP, CFO
|
Exercise / conversionRestricted Stock Units · Derivative | 4,213 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000149 · edgar.xml · derivative · entry 5 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,212 Underlying: Common Stock · 4,213 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F5 · derivative.exercise_date: 4,213 of the RSUs vested on August 1, 2018. The remaining 4,212 RSUs will vest on August 1, 2019. F5 · derivative.expiration_date: 4,213 of the RSUs vested on August 1, 2018. The remaining 4,212 RSUs will vest on August 1, 2019. Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 16:07 UTC |
Florin Daniel PExec. VP, CFO
|
Tax withholdingCommon Stock | 1,840 | $125.58 | $231,067.20 |
DisclosureSEC source: 0000911916-18-000149 · edgar.xml · nonDerivative · entry 4 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,326 F3 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 16:07 UTC |
Florin Daniel PExec. VP, CFO
|
Exercise / conversionCommon Stock | 4,213 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000149 · edgar.xml · nonDerivative · entry 3 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Includes 137 shares acquired under the ESPP on June 29, 2018. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 21:12 UTC |
Collins Tony W.VP, Controller and CAO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,670 | $0.00 Strike: $104.01 | $0.00 |
DisclosureSEC source: 0000911916-18-000147 · edgar.xml · derivative · entry 4 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,340 Underlying: Common Stock · 2,670 shares Expires 2026-03-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 2,670 options vested on March 21, 2017; 2,670 options vested on March 21, 2018; and the remaining options will vest as to 2,670 options on each of March 21, 2019 and 2020. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 21:12 UTC |
Collins Tony W.VP, Controller and CAO
|
SaleCommon Stock | 108 | $125.75 | $13,580.46 |
DisclosureSEC source: 0000911916-18-000147 · edgar.xml · nonDerivative · entry 3 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368 Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 21:12 UTC |
Collins Tony W.VP, Controller and CAO
|
SaleCommon Stock | 2,670 | $125.77 | $335,805.63 |
DisclosureSEC source: 0000911916-18-000147 · edgar.xml · nonDerivative · entry 2 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476 F2 · price: Represents the sale of 2,670 shares in multiple transactions ranging in price from $125.735 to $125.81 per share, resulting in a weighted average sale price of $125.7699. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| July 31, 2018 Filed Aug 2, 2018 21:12 UTC |
Collins Tony W.VP, Controller and CAO
|
Exercise / conversionCommon Stock | 2,670 | $104.01 | $277,706.70 |
DisclosureSEC source: 0000911916-18-000147 · edgar.xml · nonDerivative · entry 1 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 138 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between May 1, 2018 and June 29, 2018. Read SEC document |
| June 30, 2018 Filed Jul 3, 2018 20:07 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 244.771 | $0.00 Strike: $112.35 | $0.00 |
DisclosureSEC source: 0000911916-18-000136 · edgar.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,067.486 Underlying: Common Stock · 244.771 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2018 Filed Jul 3, 2018 20:08 UTC |
MICHELSON MICHAEL WDirector
|
GrantPhantom Stock Units · Derivative | 211.393 | $0.00 Strike: $112.35 | $0.00 |
DisclosureSEC source: 0000911916-18-000137 · edgar.xml · derivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,289.117 Underlying: Common Stock · 211.393 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 105.697 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: 105.697 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2018 Filed Jul 3, 2018 20:07 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 255.897 | $0.00 Strike: $112.35 | $0.00 |
DisclosureSEC source: 0000911916-18-000135 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,452.468 Underlying: Common Stock · 255.897 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2018 Filed Jul 3, 2018 20:06 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 211.393 | $0.00 Strike: $112.35 | $0.00 |
DisclosureSEC source: 0000911916-18-000134 · edgar.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,220.879 Underlying: Common Stock · 211.393 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 30, 2018 Filed Jul 3, 2018 20:05 UTC |
BOUDREAUX GAILDirector
|
GrantPhantom Stock Units · Derivative | 211.393 | $0.00 Strike: $112.35 | $0.00 |
DisclosureSEC source: 0000911916-18-000133 · edgar.xml · derivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,322.87 Underlying: Common Stock · 211.393 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2018 Filed Jul 3, 2018 20:05 UTC |
BERNARD BETSY JDirector
|
GrantPhantom Stock Units · Derivative | 244.771 | $0.00 Strike: $112.35 | $0.00 |
DisclosureSEC source: 0000911916-18-000132 · edgar.xml · derivative · entry 1 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,017.02 Underlying: Common Stock · 244.771 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. Read SEC document |
| June 30, 2018 Filed Jul 3, 2018 20:04 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantPhantom Stock Units · Derivative | 211.393 | $0.00 Strike: $112.35 | $0.00 |
DisclosureSEC source: 0000911916-18-000131 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,755.435 Underlying: Common Stock · 211.393 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director. Read SEC document |
| June 12, 2018 Filed Aug 3, 2018 16:07 UTC |
Florin Daniel PExec. VP, CFO
|
GiftCommon Stock | 245 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000149 · edgar.xml · nonDerivative · entry 2 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,816 Read SEC document |
| June 07, 2018 Filed Jun 11, 2018 20:42 UTC |
Yi SangPresident, Asia Pacific
|
GrantRestricted Stock Units · Derivative | 6,717 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000129 · edgar.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,717 Underlying: Common Stock · 6,717 shares Expires 2020-06-07 F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. Read SEC document |
| May 22, 2018 Filed May 23, 2018 21:05 UTC |
Mazur-Hofsaess KatarzynaPres., Eur., M. East & Afr.
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,765 | $0.00 Strike: $73.15 | $0.00 |
DisclosureSEC source: 0000911916-18-000127 · edgar.xml · derivative · entry 3 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,765 shares Expires 2023-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Vested annually over four years in increments of 25% each year, commencing on March 18, 2014. Read SEC document |
| May 22, 2018 Filed May 23, 2018 21:05 UTC |
Mazur-Hofsaess KatarzynaPres., Eur., M. East & Afr.
|
SaleCommon Stock | 8,765 | $113.61 | $995,795.16 |
DisclosureSEC source: 0000911916-18-000127 · edgar.xml · nonDerivative · entry 2 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,682 F1 · price: Represents the sale of 8,765 shares in multiple transactions ranging in price from $113.30 to $114.14 per share, resulting in a weighted average sale price of $113.6104. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| May 22, 2018 Filed May 23, 2018 21:05 UTC |
Mazur-Hofsaess KatarzynaPres., Eur., M. East & Afr.
|
Exercise / conversionCommon Stock | 8,765 | $73.15 | $641,159.75 |
DisclosureSEC source: 0000911916-18-000127 · edgar.xml · nonDerivative · entry 1 Mazur-Hofsaess Katarzyna · CIK 0001574684 · Pres., Eur., M. East & Afr. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2018 Filed Aug 3, 2018 16:07 UTC |
Florin Daniel PExec. VP, CFO
|
GiftCommon Stock | 264 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000149 · edgar.xml · nonDerivative · entry 1 Florin Daniel P · CIK 0001402459 · Exec. VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,061 F1 · balance_after: Includes 101 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan (the "ESPP") between December 29, 2017 and May 1, 2018. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:15 UTC |
MICHELSON MICHAEL WDirector
|
GrantRestricted Stock Units · Derivative | 1,143.159 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000126 · edgar.xml · derivative · entry 2 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,339.09 Underlying: Common Stock · 1,143.159 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:15 UTC |
MICHELSON MICHAEL WDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $113.72 | $0.00 |
DisclosureSEC source: 0000911916-18-000126 · edgar.xml · derivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,077.724 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F4 · balance_after: Includes 6.919 phantom stock units accrued on April 30, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:15 UTC |
HIGGINS ARTHUR JDirector
|
GrantRestricted Stock Units · Derivative | 1,143.159 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000125 · edgar.xml · derivative · entry 2 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,762.459 Underlying: Common Stock · 1,143.159 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:15 UTC |
HIGGINS ARTHUR JDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $113.72 | $0.00 |
DisclosureSEC source: 0000911916-18-000125 · edgar.xml · derivative · entry 1 HIGGINS ARTHUR J · CIK 0001142083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,822.715 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F4 · balance_after: Includes 43.401 phantom stock units accrued on April 30, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:14 UTC |
HAGEMANN ROBERTDirector
|
GrantRestricted Stock Units · Derivative | 1,143.159 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000124 · edgar.xml · derivative · entry 2 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,321.736 Underlying: Common Stock · 1,143.159 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:14 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $113.72 | $0.00 |
DisclosureSEC source: 0000911916-18-000124 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,196.571 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F4 · balance_after: Includes 33.848 phantom stock units accrued on April 30, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:14 UTC |
GLASSCOCK LARRY CDirector
|
GrantRestricted Stock Units · Derivative | 1,143.159 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000123 · edgar.xml · derivative · entry 2 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,389.812 Underlying: Common Stock · 1,143.159 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of the Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:14 UTC |
GLASSCOCK LARRY CDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $113.72 | $0.00 |
DisclosureSEC source: 0000911916-18-000123 · edgar.xml · derivative · entry 1 GLASSCOCK LARRY C · CIK 0001189793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,020.901 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of the Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F4 · balance_after: Includes 159.808 phantom stock units accrued between July 28, 2017 and April 30, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:13 UTC |
Farrell Michael J.Director
|
GrantRestricted Stock Units · Derivative | 1,143.159 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000122 · edgar.xml · derivative · entry 2 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,518.656 Underlying: Common Stock · 1,143.159 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:13 UTC |
Farrell Michael J.Director
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $113.72 | $0.00 |
DisclosureSEC source: 0000911916-18-000122 · edgar.xml · derivative · entry 1 Farrell Michael J. · CIK 0001485164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,009.486 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F4 · balance_after: Includes 8.839 phantom stock units accrued on April 30, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:13 UTC |
BOUDREAUX GAILDirector
|
GrantRestricted Stock Units · Derivative | 1,143.159 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000121 · edgar.xml · derivative · entry 2 BOUDREAUX GAIL · CIK 0001287920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,285.759 Underlying: Common Stock · 1,143.159 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:13 UTC |
BOUDREAUX GAILDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $113.72 | $0.00 |
DisclosureSEC source: 0000911916-18-000121 · edgar.xml · derivative · entry 1 BOUDREAUX GAIL · CIK 0001287920 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,111.477 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F4 · balance_after: Includes 15.229 phantom stock units accrued on April 30, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:12 UTC |
BERNARD BETSY JDirector
|
GrantRestricted Stock Units · Derivative | 1,143.159 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000120 · edgar.xml · derivative · entry 2 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,944.136 Underlying: Common Stock · 1,143.159 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:12 UTC |
BERNARD BETSY JDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $113.72 | $0.00 |
DisclosureSEC source: 0000911916-18-000120 · edgar.xml · derivative · entry 1 BERNARD BETSY J · CIK 0001166854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,772.249 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F4 · balance_after: Includes 18.578 phantom stock units accrued on April 30, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:12 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantRestricted Stock Units · Derivative | 1,143.159 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-18-000119 · edgar.xml · derivative · entry 2 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,285.759 Underlying: Common Stock · 1,143.159 shares Expires not disclosed F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F5 · derivative.exercise_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F5 · derivative.expiration_date: The Restricted Stock Units are immediately 100% vested and will be subject to mandatory deferral until the later of (1) the reporting person's termination of service as a Director or (2) the date that is three years after the grant date. F6 · balance_after: Includes Restricted Stock Units granted in prior years that are subject to different mandatory deferral periods. Read SEC document |
| May 15, 2018 Filed May 17, 2018 18:12 UTC |
BEGLEY CHRISTOPHER BDirector
|
GrantPhantom Stock Units · Derivative | 500 | $0.00 Strike: $113.72 | $0.00 |
DisclosureSEC source: 0000911916-18-000119 · edgar.xml · derivative · entry 1 BEGLEY CHRISTOPHER B · CIK 0001239420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,544.042 Underlying: Common Stock · 500 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F3 · derivative.expiration_date: The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director ("Annual Deferred Share Units"). F4 · balance_after: Includes 16.120 phantom stock units accrued on April 30, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| April 30, 2018 Filed May 1, 2018 20:25 UTC |
Collins Tony W.VP, Controller and CAO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,213 | $0.00 Strike: $94.34 | $0.00 |
DisclosureSEC source: 0000911916-18-000112 · edgar.xml · derivative · entry 4 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,213 shares Expires 2024-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1,214 options vested on each of March 17, 2016 and 2017; and the remaining 1,213 options vested on March 17, 2018. Read SEC document |
| April 30, 2018 Filed May 1, 2018 20:25 UTC |
Collins Tony W.VP, Controller and CAO
|
SaleCommon Stock | 117 | $116.32 | $13,609.44 |
DisclosureSEC source: 0000911916-18-000112 · edgar.xml · nonDerivative · entry 3 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338 Read SEC document |
| April 30, 2018 Filed May 1, 2018 20:25 UTC |
Collins Tony W.VP, Controller and CAO
|
SaleCommon Stock | 1,213 | $116.77 | $141,636.31 |
DisclosureSEC source: 0000911916-18-000112 · edgar.xml · nonDerivative · entry 2 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 455 F2 · price: Represents the sale of 1,213 shares in multiple transactions ranging in price from $116.22 to $117.04 per share, resulting in a weighted average sale price of $116.7653. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Read SEC document |
| April 30, 2018 Filed May 1, 2018 20:25 UTC |
Collins Tony W.VP, Controller and CAO
|
Exercise / conversionCommon Stock | 1,213 | $94.34 | $114,434.42 |
DisclosureSEC source: 0000911916-18-000112 · edgar.xml · nonDerivative · entry 1 Collins Tony W. · CIK 0001636683 · VP, Controller and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 101 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan between July 31, 2017 and January 30, 2018. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 19:12 UTC |
Rhodes Jeffrey K.Director
|
GrantPhantom Stock Units · Derivative | 218.672 | $0.00 Strike: $108.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000109 · edgar.xml · derivative · entry 1 Rhodes Jeffrey K. · CIK 0001560940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,399.51 Underlying: Common Stock · 218.672 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 109.336 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: 109.336 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 3.904 phantom stock units accrued on January 29, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 19:12 UTC |
MICHELSON MICHAEL WDirector
|
GrantPhantom Stock Units · Derivative | 218.672 | $0.00 Strike: $108.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000108 · edgar.xml · derivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,570.805 Underlying: Common Stock · 218.672 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: 109.336 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: 109.336 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 5.916 phantom stock units accrued on January 29, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2018 Filed Apr 3, 2018 19:10 UTC |
HAGEMANN ROBERTDirector
|
GrantPhantom Stock Units · Derivative | 264.708 | $0.00 Strike: $108.61 | $0.00 |
DisclosureSEC source: 0000911916-18-000106 · edgar.xml · derivative · entry 1 HAGEMANN ROBERT · CIK 0001222676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,662.723 Underlying: Common Stock · 264.708 shares Expires not disclosed F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1. F3 · derivative.exercise_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F3 · derivative.expiration_date: Units are to be settled in cash in seven annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs. F4 · balance_after: Includes 30.292 phantom stock units accrued on January 29, 2018 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.